We Ran A Stock Scan For Earnings Growth And Haleon (LON:HLN) Passed With Ease
Aug 28
Have your own idea? Try our Stock Screener
U.K. (FTSE) Healthcare Sector Analysis
UpdatedAug 30, 2025
DataAggregated Company Financials
Companies88
- 7D-1.5%
- 3M4.2%
- 1Y-9.4%
- YTD8.7%
Over the last 7 days, the Healthcare industry has dropped 1.5%, driven by a pullback from AstraZeneca of 1.5%. In contrast, Avacta Group has gained 26%. Overall the industry is down 9.4% in 12 months. Looking forward, earnings are forecast to grow by 13% annually.
Sector Valuation and Performance
Has the U.K. Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 31 Aug 2025 | UK£309.7b | UK£100.7b | UK£12.0b | 28.8x | 25.8x | 3.1x |
| Tue, 29 Jul 2025 | UK£291.3b | UK£100.0b | UK£11.0b | 31.3x | 26.6x | 2.9x |
| Thu, 26 Jun 2025 | UK£280.7b | UK£96.4b | UK£10.7b | 31.7x | 26.3x | 2.9x |
| Sat, 24 May 2025 | UK£286.9b | UK£96.9b | UK£10.7b | 29.9x | 26.7x | 3x |
| Mon, 21 Apr 2025 | UK£273.3b | UK£97.1b | UK£9.7b | 28.6x | 28.3x | 2.8x |
| Wed, 19 Mar 2025 | UK£312.1b | UK£98.1b | UK£9.6b | 27.2x | 32.7x | 3.2x |
| Fri, 14 Feb 2025 | UK£310.9b | UK£99.9b | UK£9.4b | 29.3x | 33.1x | 3.1x |
| Sun, 12 Jan 2025 | UK£254.9b | UK£87.4b | UK£7.8b | 31.3x | 32.7x | 2.9x |
| Tue, 10 Dec 2024 | UK£252.6b | UK£85.1b | UK£7.5b | 28.3x | 33.5x | 3x |
| Thu, 07 Nov 2024 | UK£238.7b | UK£83.1b | UK£7.5b | 26.8x | 32x | 2.9x |
| Sat, 05 Oct 2024 | UK£273.3b | UK£82.4b | UK£8.9b | 29x | 30.8x | 3.3x |
| Mon, 02 Sep 2024 | UK£305.5b | UK£82.1b | UK£8.8b | 34.6x | 34.5x | 3.7x |
| Wed, 31 Jul 2024 | UK£283.6b | UK£82.5b | UK£9.4b | 33.4x | 30.1x | 3.4x |
| Fri, 28 Jun 2024 | UK£282.9b | UK£82.0b | UK£9.4b | 30.2x | 30x | 3.4x |
| Sun, 26 May 2024 | UK£293.7b | UK£81.6b | UK£9.4b | 31.3x | 31.3x | 3.6x |
| Tue, 23 Apr 2024 | UK£266.9b | UK£82.1b | UK£9.7b | 29.2x | 27.5x | 3.3x |
| Thu, 21 Mar 2024 | UK£257.7b | UK£80.4b | UK£9.6b | 34x | 26.9x | 3.2x |
| Sat, 17 Feb 2024 | UK£256.3b | UK£79.8b | UK£9.4b | 35.2x | 27.1x | 3.2x |
| Mon, 15 Jan 2024 | UK£279.0b | UK£83.9b | UK£10.6b | 38.8x | 26.3x | 3.3x |
| Wed, 13 Dec 2023 | UK£262.3b | UK£84.6b | UK£10.7b | 39.4x | 24.5x | 3.1x |
| Fri, 10 Nov 2023 | UK£265.9b | UK£86.0b | UK£11.0b | 40.9x | 24.3x | 3.1x |
| Sun, 08 Oct 2023 | UK£277.9b | UK£85.7b | UK£10.3b | 41.5x | 26.9x | 3.2x |
| Tue, 05 Sep 2023 | UK£271.2b | UK£84.3b | UK£10.2b | 43.8x | 26.6x | 3.2x |
| Thu, 03 Aug 2023 | UK£277.5b | UK£83.7b | UK£10.2b | 41.5x | 27.2x | 3.3x |
| Sat, 01 Jul 2023 | UK£280.3b | UK£82.7b | UK£7.9b | 44.3x | 35.6x | 3.4x |
| Mon, 29 May 2023 | UK£287.9b | UK£83.9b | UK£8.0b | 47.6x | 35.9x | 3.4x |
| Wed, 26 Apr 2023 | UK£301.6b | UK£84.3b | UK£6.9b | 47.6x | 43.7x | 3.6x |
| Fri, 24 Mar 2023 | UK£275.5b | UK£84.8b | UK£7.0b | 40.2x | 39.6x | 3.3x |
| Sun, 19 Feb 2023 | UK£288.1b | UK£85.5b | UK£7.4b | 41.7x | 38.7x | 3.4x |
| Tue, 17 Jan 2023 | UK£291.3b | UK£94.7b | UK£6.6b | 35.8x | 44.3x | 3.1x |
| Thu, 15 Dec 2022 | UK£285.1b | UK£94.0b | UK£6.6b | 37.3x | 43.4x | 3x |
| Sat, 12 Nov 2022 | UK£266.8b | UK£96.3b | UK£6.7b | 34.5x | 39.8x | 2.8x |
| Mon, 10 Oct 2022 | UK£263.7b | UK£96.9b | UK£4.0b | 34.5x | 66.1x | 2.7x |
| Wed, 07 Sep 2022 | UK£265.9b | UK£94.9b | UK£4.1b | 34.8x | 65.5x | 2.8x |
Price to Earnings Ratio
65.5x
Current Industry PE
- Investors are pessimistic on the British Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 25.8x which is lower than its 3-year average PE of 36.0x.
- The industry is trading close to its 3-year average PS ratio of 3.3x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 43% per year over the last three years, while revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare sector?
| GB Market | 2.67% | |
| Healthcare | -1.49% | |
| Biotech | 0.59% | |
| Medical Equipment | -0.67% | |
| Healthcare Services | -1.39% | |
| Pharma | -1.49% | |
| Healthtech | -3.32% | |
| Life Sciences | -11.79% | |
Industry PE
- Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 23.1%, which is lower than the prior year's growth of 58.9% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 34% over the next 5 years.
- This is better than its past earnings decline of 34% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 13% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AVCT Avacta Group | UK£0.61 | 25.5% +UK£48.6m | -14.0% | PS2115.4x | |
| OXB Oxford Biomedica | UK£5.66 | 4.4% +UK£28.8m | 69.0% | PS5.3x | |
| NIOX NIOX Group | UK£0.76 | 9.2% +UK£26.7m | 12.8% | PE93.4x | |
| IDHC Integrated Diagnostics Holdings | US$0.49 | 13.3% +US$33.1m | 30.2% | PE12.8x | |
| HEMO Hemogenyx Pharmaceuticals | UK£5.30 | 208.1% +UK£18.6m | 1.2% | PB29.8x |
